Covid-19 vaccine: Bharat Biotech to use Kansas firm's adjuvant for Covaxin

Adjuvants may be added to a vaccine to produce more antibodies and longer lasting immunity thus minimising the dose of antigen needed

Hyderabad based Bharat Biotech, whose Covid-19 vaccine candidate Covaxin is one of the leading candidates from India, will use adjuvant from Kansas vased ViroVax for its vaccine to boost immune response and longer lasting immunity.

Vaccines typically use adjuvants to improve the immune response. Adjuvants are pharmacological or immunological agents that improve the immune response of a vaccine. It may be added to a vaccine to produce more antibodies and longer lasting immunity thus minimising the dose of antigen needed. An antigen is any substance that causes our immune system to produce antibodies against it. It can be any substance